By
Drug Target Review2023-12-15T16:00:01
A new deep-learning method could enhance therapeutic devices for people with neurological or mental health conditions.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T13:04:00Z
2026-06-19T08:26:00Z
2026-06-17T12:40:00Z
2024-01-26T13:22:42
Sponsored by bit.bio
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., By Drug Target Review
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2024-02-06T08:57:06
Sponsored by bit.bio
Site powered by Webvision Cloud